Literature DB >> 7447426

Relative resistance to erythromycin in Chlamydia trachomatis.

A Mourad, R L Sweet, N Sugg, J Schachter.   

Abstract

Recent Chlamydia trachomatis isolates were tested in a tissue culture system for susceptibility to tetracycline, erythromycin, rosaramicin, rifampin, and clindamycin. Rifampin was the most active drug (minimal inhibitory concentration, less than or equal to 0.02 microgram/ml). Tetracycline and rasaramicin were highly active, with a concentration of less than or equal to 0.25 microgram/ml being chlamydicidal. Clindamycin was least active on a weight basis, requiring up to 16 microgram/ml to prevent the passage of chlamydiae into a drug-free tissue culture system. Relative resistance to erythromycin was detected; two isolates were capable of limited replication in 1 microgram/ml.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7447426      PMCID: PMC284078          DOI: 10.1128/AAC.18.5.696

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  9 in total

1.  Antibiotic susceptibility of Chlamydia trachomatis.

Authors:  H J Blackman; C Yoneda; C R Dawson; J Schachter
Journal:  Antimicrob Agents Chemother       Date:  1977-12       Impact factor: 5.191

2.  A method for testing the antibiotic susceptibility of Chlamydia trachomatis in a cell culture system.

Authors:  G L Ridgway; J M Owen; J D Oriel
Journal:  J Antimicrob Chemother       Date:  1976-03       Impact factor: 5.790

3.  Antimicrobial activity of several antibiotics and a sulfonamide against Chlamydia trachomatis organisms in cell culture.

Authors:  C C Kuo; S P Wang; J T Grayston
Journal:  Antimicrob Agents Chemother       Date:  1977-07       Impact factor: 5.191

Review 4.  Chlamydial infections (third of three parts).

Authors:  J Schachter
Journal:  N Engl J Med       Date:  1978-03-09       Impact factor: 91.245

5.  Emergence of rifampin-resistance in Chlamydia trachomatis.

Authors:  H Keshishyan; L Hanna; E Jawetz
Journal:  Nature       Date:  1973-07-20       Impact factor: 49.962

6.  Immunologic relationship between genital TRIC, lymphogranuloma venereum, and related organisms in a new microtiter indirect immunofluorescence test.

Authors:  S P Wang; J T Grayston
Journal:  Am J Ophthalmol       Date:  1970-09       Impact factor: 5.258

7.  In vitro susceptibility of 30 strains of Chlamydia trachomatis to rosamicin.

Authors:  T F Smith; H E Washton
Journal:  Antimicrob Agents Chemother       Date:  1978-09       Impact factor: 5.191

8.  Rifapicin inhibition of trachoma agent in vivo.

Authors:  Y Becker; Y Asher; N Himmel; Z Zakay-Rones; B Maythar
Journal:  Nature       Date:  1969-10-04       Impact factor: 49.962

9.  Prediction of efficacy of antimicrobial agents in treatment of infections due to Chlamydia trachomatis.

Authors:  W R Bowie; C K Lee; E R Alexander
Journal:  J Infect Dis       Date:  1978-11       Impact factor: 5.226

  9 in total
  29 in total

1.  In vitro evaluation of activities of azithromycin, erythromycin, and tetracycline against Chlamydia trachomatis and Chlamydia pneumoniae.

Authors:  L E Welsh; C A Gaydos; T C Quinn
Journal:  Antimicrob Agents Chemother       Date:  1992-02       Impact factor: 5.191

2.  Is a test of cure necessary following treatment for cervical infection with Chlamydia trachomatis?

Authors:  K W Radcliffe; D Rowen; D E Mercey; G Mumtaz; G L Ridgway; A J Robinson; J S Bingham
Journal:  Genitourin Med       Date:  1990-12

Review 3.  Antibiotic resistance in Chlamydiae.

Authors:  Kelsi M Sandoz; Daniel D Rockey
Journal:  Future Microbiol       Date:  2010-09       Impact factor: 3.165

4.  In vitro evaluation of CP-62,993, erythromycin, clindamycin, and tetracycline against Chlamydia trachomatis.

Authors:  M Walsh; E W Kappus; T C Quinn
Journal:  Antimicrob Agents Chemother       Date:  1987-05       Impact factor: 5.191

Review 5.  Susceptibility testing of Chlamydia trachomatis: from eggs to monoclonal antibodies.

Authors:  J M Ehret; F N Judson
Journal:  Antimicrob Agents Chemother       Date:  1988-09       Impact factor: 5.191

Review 6.  Gynecological chlamydial infections.

Authors:  L Weström
Journal:  Infection       Date:  1982       Impact factor: 3.553

7.  Lack of in vitro activity of cefoxitin, cefamandole, cefuroxime, and piperacillin against Chlamydia trachomatis.

Authors:  W R Bowie
Journal:  Antimicrob Agents Chemother       Date:  1982-02       Impact factor: 5.191

8.  Neonatal chlamydial eye infection: an epidemiological and clinical study.

Authors:  K Persson; R Rönnerstam; L Svanberg; M A Pohla
Journal:  Br J Ophthalmol       Date:  1983-10       Impact factor: 4.638

9.  In vitro activity of azithromycin (CP-62,993) against Chlamydia trachomatis and Chlamydia pneumoniae.

Authors:  A Agacfidan; J Moncada; J Schachter
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

10.  Epidemiology and therapy of Chlamydia trachomatis infections.

Authors:  W R Bowie
Journal:  Drugs       Date:  1984-05       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.